ClinicalTrials.Veeva

Menu

Cell-Based Noninvasive Prenatal Testing (NIPT)

L

Luna Genetics

Status

Enrolling

Conditions

Pregnancy Related

Treatments

Diagnostic Test: Redraw for analysis of blood samples from healthy pregnant women

Study type

Interventional

Funder types

Industry

Identifiers

NCT05245266
Luna IRB LG-003

Details and patient eligibility

About

The purpose of the overall study is to develop improved methods for recovery and analysis of fetal cells from the mother's blood in order to develop clinically useful forms of cell-based, diagnostic, noninvasive prenatal testing (NIPT). Luna genetics will obtain and analyze research blood samples from healthy pregnant women. A phlebotomist will be sent to any location in the United States to collect the blood samples. Sample identifiers will be removed as the first step so that laboratory personnel will not see or have access to identifiers.

Enrollment

500 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria for healthy pregnant subjects:

  • Pregnant
  • 18 years or older
  • 65 or younger

Exclusion Criteria for healthy pregnant subjects:

  • Acute illness
  • Unavailability of maternal blood sample of at least 30 ml
  • Language barrier (non-English speaking )
  • Maternal age of less than 18 years, or over 65
  • Higher order multiple pregnancy (triplet or greater)

Trial design

Primary purpose

Diagnostic

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

500 participants in 1 patient group

Analysis of blood samples from healthy pregnant women
Other group
Description:
Analysis of blood samples from healthy pregnant women. A phlebotomist will be sent to any location in the United States to collect the blood sample. Sample identifiers will be removed as the first step so that laboratory personnel will not see or have access to identifiers. No information will go back to patients or their physicians.
Treatment:
Diagnostic Test: Redraw for analysis of blood samples from healthy pregnant women

Trial contacts and locations

1

Loading...

Central trial contact

Michelle Bellair, MSc.; April O' Connor, MS, LCGC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems